Citation Impact
Citing Papers
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
2000 StandoutScience
Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
1996
Coordinate Regulation of the Expression of the Fatty Acid Transport Protein and Acyl-CoA Synthetase Genes by PPARα and PPARγ Activators
1997
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
1997 Standout
Rosiglitazone (BRL49653), a PPARγ-selective agonist, causes peroxisome proliferator-like liver effects in obese mice
1999
SRC-1 and TIF2 Control Energy Balance between White and Brown Adipose Tissues
2002
Alterations in Lipoprotein Metabolism in Peroxisome Proliferator-activated Receptor α-deficient Mice
1997
The Many Faces of PPARγ
2005
mTOR Signaling in Growth Control and Disease
2012 Standout
Inflammation and metabolic disorders
2006 StandoutNature
Syndromes Associated with Insulin Resistance and Acanthosis Nigricans
1998
The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor γ2 gene is not associated with postprandial responses to glucose or fat tolerance tests in young healthy subjects: the European Atherosclerosis Research Study II
2000
Estimating African American Admixture Proportions by Use of Population-Specific Alleles
1998
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
2012 StandoutNature
Identification of a Functional Peroxisome Proliferator-responsive Element in the Murine Fatty Acid Transport Protein Gene
1999
Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta
1999
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
2006 StandoutNature
Development of a Novel Polygenic Model of NIDDM in Mice Heterozygous for IR and IRS-1 Null Alleles
1997
Confronting Complexity: the Interlink of Phototransduction and Retinoid Metabolism in the Vertebrate Retina
2001
Peroxisome Proliferator-activated Receptor α Activates Transcription of the Brown Fat Uncoupling Protein-1 Gene
2001
PPARγ insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-κB signaling pathway
2005
Peroxisome proliferator-activated receptor γ in diabetes and metabolism
2004
A genome-wide comparison of recent chimpanzee and human segmental duplications
2005 StandoutNatureNobel
Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies
2005
Impact of the Pro12Ala polymorphism of the PPAR-γ2 gene on serum triacylglycerol response to n−3 fatty acid supplementation
2003
Regulating Adipogenesis
1997
DNA duplication associated with Charcot-Marie-Tooth disease type 1A
1991 Standout
Adipocytes as regulators of energy balance and glucose homeostasis
2006 StandoutNature
Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptors
2003
Multiple roles of PPARα in brown adipose tissue under constitutive and cold conditions
2009
Understanding the recent evolution of the human genome: insights from human-chimpanzee genome comparisons
2006
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Abundant gene conversion between arms of palindromes in human and ape Y chromosomes
2003 Nature
Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones
2001
Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins
1994 StandoutNobel
An Analysis of Linkage Disequilibrium in the Interleukin-1 Gene Cluster, Using a Novel Grouping Method for Multiallelic Markers
1998
Polarity and Specific Sequence Requirements of Peroxisome Proliferator-activated Receptor (PPAR)/Retinoid X Receptor Heterodimer Binding to DNA
1997
PPAR and human metabolic disease
2006
Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity
2002
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
1997 StandoutNature
Molecular phylogeny of the hominoids: inferences from multiple independent DNA sequence data sets
1997
PRDM16 controls a brown fat/skeletal muscle switch
2008 StandoutNature
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.
1994
Gene Expression and Physiologic Responses of the Heart to the Initiation and Withdrawal of Caloric Restriction
2006
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
1998 StandoutNature
Adipose Development: From Stem Cell to Adipocyte
2005
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
1998 Standout
Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences
1999
Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays
1999
Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver
1999
Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene
1997
Increased insulin clearance in peroxisome proliferator-activated receptor γ2 Pro12Ala
2003
FOXC2 Is a Winged Helix Gene that Counteracts Obesity, Hypertriglyceridemia, and Diet-Induced Insulin Resistance
2001
Expression of Putative Fatty Acid Transporter Genes Are Regulated by Peroxisome Proliferator-activated Receptor α and γ Activators in a Tissue- and Inducer-specific Manner
1998
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
A PPARγ mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus
2000
Peroxisome Proliferator-Activated Receptor (PPAR) γ and Retinoid X Receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle
2001
Haplotypes of Angiotensinogen in Essential Hypertension
1997
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
The Nuclear Receptors Peroxisome Proliferator-activated Receptor α and Rev-erbα Mediate the Species-specific Regulation of Apolipoprotein A-I Expression by Fibrates
1998
Identification of ARA70 as a Ligand-enhanced Coactivator for the Peroxisome Proliferator-activated Receptor γ
1999
Altered function of insulin receptor substrate-1–deficient mouse islets and cultured β-cell lines
1999
Insulin signalling and the regulation of glucose and lipid metabolism
2001 StandoutNature
Inflammation in atherosclerosis
2002 StandoutNature
A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
1998
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
The hormone resistin links obesity to diabetes
2001 StandoutNature
A futile metabolic cycle activated in adipocytes by antidiabetic agents
2002
Haplotype analysis of the PPARγ Pro12Ala and C1431T variants reveals opposing associations with body weight
2002
PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
1999 Standout
Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice
1998
Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency
2000
Positive selection on the human genome
2004
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Inference of Population Structure Using Multilocus Genotype Data
2000 Standout
Atherosclerosis
2000 StandoutNature
Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin
2004
Allelic inactivation regulates olfactory receptor gene expression
1994 StandoutNobel
Common polymorphisms in the PPARγ2 and IRS-1 genes and their interaction influence serum adiponectin concentration in young Finnish men
2005
A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes
2001
A fine-scale comparison of the human and chimpanzee genomes: linkage, linkage disequilibrium and sequence analysis
1996
Activation of Proliferator-activated Receptors α and γ Induces Apoptosis of Human Monocyte-derived Macrophages
1998
Fibrates Increase Human REV-ERBα Expression in Liver via a Novel Peroxisome Proliferator-Activated Receptor Response Element
1999
Roles of PPARs in health and disease
2000 StandoutNature
Thiazolidinediones Suppress Endothelin-1 Secretion from Bovine Vascular Endothelial Cells: A New Possible Role of PPARγ on Vascular Endothelial Function
1999
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
Characterization of a high affinity cocaine binding site in rat brain
1986
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.
1993
Hypertriglyceridemia as a Result of Human apo CII Gene Expression in Transgenic Mice
1990 Science
Molecular Genetics of Human Blue Cone Monochromacy
1989 Science
A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine
1987
Parallel Patterns of Evolution in the Genomes and Transcriptomes of Humans and Chimpanzees
2005 StandoutScienceNobel
Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins.
1994
Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals.
1995 StandoutNobel
Identification of DNA cleavage- and recombination-specific hnRNP cofactors for activation-induced cytidine deaminase
2015 StandoutNobel
Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease
1999
GENETICS OF NON-INSULIN-DEPENDENT (TYPE-II) DIABETES MELLITUS
1996
Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene
2001 StandoutNobel
Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes.
1999
Fat and Beyond: The Diverse Biology of PPARγ
2008 Standout
Visual Pigment Gene Structure and the Severity of Color Vision Defects
1996 Science
Conditional Disruption of the Peroxisome Proliferator-Activated Receptor γ Gene in Mice Results in Lowered Expression of ABCA1, ABCG1, and apoE in Macrophages and Reduced Cholesterol Efflux
2002
Reconstructing the DNA Methylation Maps of the Neandertal and the Denisovan
2014 StandoutScienceNobel
Thiazolidinediones and insulin resistance: Peroxisome proliferatoractivated receptor γ activation stimulates expression of the CAP gene
1998
Heterozygous α 2A -adrenergic receptor mice unveil unique therapeutic benefits of partial agonists
2002 StandoutNobel
Extensive Nuclear DNA Sequence Diversity Among Chimpanzees
1999 StandoutScienceNobel
Impaired insulin secretion and glucose intolerance in synaptotagmin-7 null mutant mice
2008 StandoutNobel
Genetic Variation in the Peroxisome Proliferator–Activated Receptor-γ2 Gene (Pro12Ala) Affects Metabolic Responses to Weight Loss and Subsequent Weight Regain
2001
Cardiovascular Regulation in Mice Lacking α 2 -Adrenergic Receptor Subtypes b and c
1996 StandoutScienceNobel
Osteopontin Is Expressed in Human Aortic Valvular Lesions
1995
DNA Banks for Endangered Animal Species
2000 StandoutScienceNobel
The Proline 12 Alanine Substitution in the Peroxisome Proliferator–Activated Receptor-γ2 Gene Is Associated With Lower Lipoprotein Lipase Activity in Vivo
2002
Regulation of Peroxisome Proliferator–Activated Receptor-γ Activity by Mammalian Target of Rapamycin and Amino Acids in Adipogenesis
2004
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
The Peroxisome Proliferator-Activated Receptor-γ2 Pro12Ala Polymorphism
2002
Global Patterns of Linkage Disequilibrium at the CD4 Locus and Modern Human Origins
1996 StandoutScienceNobel
Molecular genetics of speciation and human origins.
1994
Essential Role of Insulin Receptor Substrate 1 in Differentiation of Brown Adipocytes
2001
Regulation of Peroxisome Proliferator-Activated Receptor γ Expression by Adipocyte Differentiation and Determination Factor 1/Sterol Regulatory Element Binding Protein 1: Implications for Adipocyte Differentiation and Metabolism
1999
Peroxisome Proliferator Activated Receptor-α Expression in Human Liver
1998
Peroxisome proliferator activated receptor-alpha expression in human liver.
1998
Fibrates Suppress Fibrinogen Gene Expression in Rodents Via Activation of the Peroxisome Proliferator-Activated Receptor-
1999
daf-2 , an Insulin Receptor-Like Gene That Regulates Longevity and Diapause in Caenorhabditis elegans
1997 StandoutScienceNobel
Lipoprotein Mutations in Pigs Are Associated with Elevated Plasma Cholesterol and Atherosclerosis
1986 Science
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
Human placenta protein-tyrosine-phosphatase: amino acid sequence and relationship to a family of receptor-like proteins.
1989 StandoutNobel
NUCLEAR RECEPTORS IN MACROPHAGE BIOLOGY: At the Crossroads of Lipid Metabolism and Inflammation
2004
Recent progress in understanding apolipoprotein B.
1990
Effect of Peroxisome Proliferator-Activated Receptor Alpha Activators on Tumor Necrosis Factor Expression in Mice during Endotoxemia
1999
Role of Skeletal Muscle in Thiazolidinedione Insulin Sensitizer (PPARγ Agonist) Action
1998
Association Between Peroxisome Proliferator–Activated Receptor γ Haplotypes and the Metabolic Syndrome in French Men and Women
2005
Evidence for Gene-Nutrient Interaction at the PPARγ Locus
2001
Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension.
1995 StandoutNobel
Peroxisome Proliferator-Activated Receptor Gamma Activators Inhibit Gene Expression and Migration in Human Vascular Smooth Muscle Cells
1998
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
Structure of the Sec23p/24p and Sec13p/31p complexes of COPII
2001 StandoutNobel
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
1987 StandoutScience
Perinatal expression of genes that may participate in lipid metabolism by lipid-laden lung fibroblasts
1998
Pro12Ala Polymorphism in the Peroxisome Proliferator–Activated Receptor-γ2 Gene Is Associated With Increased Antilipolytic Insulin Sensitivity
2001
Protein sequencing by tandem mass spectrometry.
1986
Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration
2002 StandoutNobel
PPARγ Activation in Human Endothelial Cells Increases Plasminogen Activator Inhibitor Type-1 Expression
1999
Works of S S Deeb being referenced
Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease
1996
PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.
1996
Insulin receptor substrate-1 variants in non-insulin-dependent diabetes.
1994
Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques.
1992
Analysis of red/green color discrimination in subjects with a single X-linked photopigment gene
1999
Partial gene duplication involving exon-Alu interchange results in lipoprotein lipase deficiency.
1990
Molecular Genetics of Apolipoproteins and Coronary Heart Disease
1986
Molecular patterns of X chromosome-linked color vision genes among 134 men of European ancestry.
1989
The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes.
1988
A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity.
1995
Involvement of second messengers in regulation of the low-density lipoprotein receptor gene.
1989
Sequence divergence of the red and green visual pigments in great apes and humans.
1994
A partial cDNA clone for human apolipoprotein B.
1985
Chromosomal localization of the human apolipoprotein B gene and detection of homologous RNA in monkey intestine.
1986
Genotype-phenotype relationships in human red/green color-vision defects: molecular and psychophysical studies.
1992
The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity.
1994
Regulation of the low density lipoprotein receptor and hydroxymethylglutaryl coenzyme A reductase genes by protein kinase C and a putative negative regulatory protein.
1989
Two Polymorphisms in the Peroxisome Proliferator-Activated Receptor-γ Gene Are Associated with Severe Overweight among Obese Women*
1999
A mutation in the human apolipoprotein A-I gene. Dominant effect on the level and characteristics of plasma high density lipoproteins
1991
Coexistence of abnormalities of hepatic lipase and lipoprotein lipase in a large family.
1990
Molecular basis of abnormal red-green color vision: a family with three types of color vision defects.
1988
Selective expression of human X chromosome-linked green opsin genes.
1992